Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mali
Mali: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 81.0% in 2025. ▲ Rising
Latest (2025)
81.0%
Change on year
unchanged
World rank
113th
of 194 countries
All-time high
81.0%
in 2024
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mali, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Mali is 81.0%, measured in 2025. That is the highest value across all 18 years on record.
The figure is up 28.6% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Mali peaked at 81.0% in 2024 and was at its lowest, 0.0%, in 2008.
Mali ranks 113th of 194 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mali, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 56.0% | — |
| 2012 | 58.0% | +3.6% |
| 2013 | 59.0% | +1.7% |
| 2014 | 56.0% | -5.1% |
| 2015 | 63.0% | +12.5% |
| 2016 | 71.0% | +12.7% |
| 2017 | 74.0% | +4.2% |
| 2018 | 73.0% | -1.4% |
| 2019 | 74.0% | +1.4% |
| 2020 | 66.0% | -10.8% |
| 2021 | 74.0% | +12.1% |
| 2022 | 74.0% | +0.0% |
| 2023 | 78.0% | +5.4% |
| 2024 | 81.0% | +3.8% |
| 2025 | 81.0% | +0.0% |
Mali compared with similar countries
- Mali's 81.0% is above the median for low income countries, which is 80.0%, 1.0× the median. (25 countries reporting)
- Mali's 81.0% is below the median for Sub-Saharan Africa, which is 82.5%, 98% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 58.4% | 0.0% | 74.0% | 10 |
| 2020s | 75.7% | 66.0% | 81.0% | 6 |
Countries ranked near Mali
More health data for Mali
- Un projection of annual infant deaths, annual growth rate -1.65 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.18 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 878 deaths per 1,000 people (2090)
- Number of infants who die before age 1 24,194 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 14 (2025)
- Population ages 00-04, female, annual growth rate 2.27 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0853 units per person (2025)
- Population ages 00-04, male, annual growth rate 2.19 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Mali?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Mali was 81.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Mali?
- The highest recorded value was 81.0% in 2024.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Mali?
- The lowest recorded value was 0.0% in 2008.
- How does Mali rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Mali ranks 113th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Mali?
- Over the last ten years it is up 28.6%. The long-run trend across the full record is rising.
- Where does this Mali data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).